Portal Vein Thrombosis in Adults without Cirrhosis

Purpose of Review The management of non-cirrhotic, non-tumoral portal vein thrombosis (PVT) has historically been challenging due to a paucity of data. The purpose of this review is to summarize the recommendations from major society guidelines and to highlight emerging evidence from recent years. R...
Ausführliche Beschreibung

Purpose of Review The management of non-cirrhotic, non-tumoral portal vein thrombosis (PVT) has historically been challenging due to a paucity of data. The purpose of this review is to summarize the recommendations from major society guidelines and to highlight emerging evidence from recent years. Recent Findings While direct oral anticoagulants are increasingly used for the treatment of non-cirrhotic PVT, prospective comparison with warfarin or low molecular weight heparin remains uninvestigated in this population. There is growing evidence that optimal treatment requires a tailored approach based on the underlying etiology of PVT, with options ranging from a relatively short course of anticoagulation to an aggressive combined medical/procedural approach. Summary Anticoagulation remains the mainstay of treatment for non-cirrhotic PVT. Current therapies are effective at reducing the risk of both immediate complications and long-term sequelae. Future studies should focus on refining the preferred approach to treatment based on etiology of PVT. Ausführliche Beschreibung